Do overly complex reporting guidelines remove the focus from good clinical trials?

J. Howick
, R. Webster
, J.A. Knottnerus^*
, D. Moher^*

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Article number	n1793
Number of pages	3
Journal	BMJ
Volume	374
DOIs	https://doi.org/10.1136/bmj.n1793
Publication status	Published - 16 Aug 2021

Keywords

QUALITY
RELAPSE PREVENTION
SCHIZOPHRENIA
STATEMENT

Access to Document

10.1136/bmj.n1793Licence: CC BY-NC

https://eprints.whiterose.ac.uk/177647/3/howickmoher%20accepted%20manuscript.pdf

Cite this

@article{20afbc7dc771430c81e1e837d3fde1c6,

title = "Do overly complex reporting guidelines remove the focus from good clinical trials?",

keywords = "QUALITY, RELAPSE PREVENTION, SCHIZOPHRENIA, STATEMENT",

author = "J. Howick and R. Webster and J.A. Knottnerus and D. Moher",

year = "2021",

month = aug,

day = "16",

doi = "10.1136/bmj.n1793",

language = "English",

volume = "374",

journal = "BMJ",

issn = "1756-1833",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Do overly complex reporting guidelines remove the focus from good clinical trials?

AU - Howick, J.

AU - Webster, R.

AU - Knottnerus, J.A.

AU - Moher, D.

PY - 2021/8/16

Y1 - 2021/8/16

KW - QUALITY

KW - RELAPSE PREVENTION

KW - SCHIZOPHRENIA

KW - STATEMENT

U2 - 10.1136/bmj.n1793

DO - 10.1136/bmj.n1793

M3 - Editorial

C2 - 34400403

SN - 1756-1833

VL - 374

JO - BMJ

JF - BMJ

M1 - n1793

ER -